AcelRx Pharmaceuticals Inc R5X-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:04 AM CET
1.47quote price arrow down-0.03 (-2.20%)
52 week range
0.72 - 2.33

...

Loading . . .

KEY STATS

  • Open1.47
  • Day High1.47
  • Day Low1.47
  • Prev Close1.50
  • 52 Week High2.33
  • 52 Week High Date02/09/21
  • 52 Week Low0.72
  • 52 Week Low Date03/24/20
  • Market Cap157.43M
  • Shares Out90.48M
  • 10 Day Average Volume2,490.7
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change25.55

RATIOS/PROFITABILITY

  • EPS (TTM)-0.48
  • P/E (TTM)-3.06
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest AcelRx Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AcelRx Pharmaceuticals, Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidates include DSUVIA (known as DZUVEO in Europe) and Zalviso. Its DSUVIA is indicated for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain. DSUVIA is designed to provide rapid...
Adrian Adams
Chairman
Vincent Angotti
Chief Executive Officer
Raffi Asadorian
Chief Financial Officer
Address
351 Galveston Dr
Redwood City, CA
94063-4736
United States